Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 30053 | 175 | 23.9 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 141 | 3 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS | 64640 |
| 373 | 2 | MYCOBACTERIUM TUBERCULOSIS//TUBERCULOSIS//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | 17241 |
| 30053 | 1 | Z 100//BCG VIABILITY//N N DILAURYL CHITOSAN | 175 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | Z 100 | authKW | 1932793 | 7% | 92% | 12 |
| 2 | BCG VIABILITY | authKW | 872442 | 3% | 100% | 5 |
| 3 | N N DILAURYL CHITOSAN | authKW | 523465 | 2% | 100% | 3 |
| 4 | HELPER T CELL RESPONSES | authKW | 232650 | 1% | 67% | 2 |
| 5 | NATURAL IMMUNOMODULATOR | authKW | 232650 | 1% | 67% | 2 |
| 6 | ANTI IL 4 MAB | authKW | 174488 | 1% | 100% | 1 |
| 7 | ANTINEOPLASTIC GLYCANS | authKW | 174488 | 1% | 100% | 1 |
| 8 | ATTOGLOW R | authKW | 174488 | 1% | 100% | 1 |
| 9 | B16 BL6 MELANOMA CELL | authKW | 174488 | 1% | 100% | 1 |
| 10 | BACTERIAL INTEGUMENT | authKW | 174488 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOLOGY, MISCELLANEOUS | 1014 | 2% | 0% | 3 |
| 2 | Microbiology | 628 | 26% | 0% | 45 |
| 3 | Pharmacology & Pharmacy | 116 | 17% | 0% | 30 |
| 4 | Immunology | 82 | 12% | 0% | 21 |
| 5 | Biotechnology & Applied Microbiology | 69 | 10% | 0% | 17 |
| 6 | Biochemical Research Methods | 68 | 7% | 0% | 13 |
| 7 | Oncology | 67 | 12% | 0% | 21 |
| 8 | Food Science & Technology | 28 | 6% | 0% | 10 |
| 9 | Chemistry, Analytical | 28 | 7% | 0% | 12 |
| 10 | Infectious Diseases | 20 | 4% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ENVIROMENTAL GERONTOL | 174488 | 1% | 100% | 1 |
| 2 | MOH RF | 174488 | 1% | 100% | 1 |
| 3 | PHARM TB | 174488 | 1% | 100% | 1 |
| 4 | SERV MICROBIOOL PARASITOL | 174488 | 1% | 100% | 1 |
| 5 | UMR 6236 CNRS | 174488 | 1% | 100% | 1 |
| 6 | CLIN MEDAOBA KU | 87243 | 1% | 50% | 1 |
| 7 | MULTICISCIPLINARY ADV MAT | 87243 | 1% | 50% | 1 |
| 8 | BRANCH GYNECOL CANC | 43621 | 1% | 25% | 1 |
| 9 | TB MC 964 | 43621 | 1% | 25% | 1 |
| 10 | UPCAM ISM2 | 43621 | 1% | 25% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MICROBIOS | 9089 | 5% | 1% | 9 |
| 2 | ACTA PHYSIOLOGICA LATINOAMERICANA | 6399 | 1% | 2% | 2 |
| 3 | BIOTHERAPY | 5336 | 2% | 1% | 3 |
| 4 | NATURAL IMMUNITY | 5017 | 1% | 1% | 2 |
| 5 | JOURNAL OF BIOLOGICAL STANDARDIZATION | 3796 | 2% | 1% | 3 |
| 6 | PHARMACOPEIAL FORUM | 3352 | 1% | 1% | 2 |
| 7 | MICROBIOLOGY AND IMMUNOLOGY | 1876 | 4% | 0% | 7 |
| 8 | BIOLOGICALS | 1150 | 2% | 0% | 3 |
| 9 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 1061 | 4% | 0% | 7 |
| 10 | CANCER DETECTION AND PREVENTION | 988 | 2% | 0% | 3 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | Z 100 | 1932793 | 7% | 92% | 12 | Search Z+100 | Search Z+100 |
| 2 | BCG VIABILITY | 872442 | 3% | 100% | 5 | Search BCG+VIABILITY | Search BCG+VIABILITY |
| 3 | N N DILAURYL CHITOSAN | 523465 | 2% | 100% | 3 | Search N+N+DILAURYL+CHITOSAN | Search N+N+DILAURYL+CHITOSAN |
| 4 | HELPER T CELL RESPONSES | 232650 | 1% | 67% | 2 | Search HELPER+T+CELL+RESPONSES | Search HELPER+T+CELL+RESPONSES |
| 5 | NATURAL IMMUNOMODULATOR | 232650 | 1% | 67% | 2 | Search NATURAL+IMMUNOMODULATOR | Search NATURAL+IMMUNOMODULATOR |
| 6 | ANTI IL 4 MAB | 174488 | 1% | 100% | 1 | Search ANTI+IL+4+MAB | Search ANTI+IL+4+MAB |
| 7 | ANTINEOPLASTIC GLYCANS | 174488 | 1% | 100% | 1 | Search ANTINEOPLASTIC+GLYCANS | Search ANTINEOPLASTIC+GLYCANS |
| 8 | ATTOGLOW R | 174488 | 1% | 100% | 1 | Search ATTOGLOW+R | Search ATTOGLOW+R |
| 9 | B16 BL6 MELANOMA CELL | 174488 | 1% | 100% | 1 | Search B16+BL6+MELANOMA+CELL | Search B16+BL6+MELANOMA+CELL |
| 10 | BACTERIAL INTEGUMENT | 174488 | 1% | 100% | 1 | Search BACTERIAL+INTEGUMENT | Search BACTERIAL+INTEGUMENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GARRIDO, JL , KLEGERMAN, ME , REYES, HR , GROVES, MJ , (1997) ANTINEOPLASTIC ACTIVITY OF BCG: LOCATION OF ANTINEOPLASTIC GLYCANS IN THE CELLULAR INTEGUMENT OF MYCOBACTERIUM BOVIS, BCG VACCINE, CONNAUGHT SUBSTRAIN.CYTOBIOS. VOL. 90. ISSUE 360. P. 47 -65 | 16 | 67% | 1 |
| 2 | UGAROVA, NN , LOMAKINA, GY , MODESTOVA, Y , CHERNIKOV, SV , VINOKUROVA, NV , OTRASHEVSKAYA, EV , GORBACHEV, VY , (2016) A SIMPLIFIED ATP METHOD FOR THE RAPID CONTROL OF CELL VIABILITY IN A FREEZE-DRIED BCG VACCINE.JOURNAL OF MICROBIOLOGICAL METHODS. VOL. 130. ISSUE . P. 48 -53 | 10 | 63% | 0 |
| 3 | GROVES, MJ , (1993) PHARMACEUTICAL CHARACTERIZATION OF MYCOBACTERIUM-BOVIS BACILLUS-CALMETTE-GUERIN (BCG) VACCINE USED FOR THE TREATMENT OF SUPERFICIAL BLADDER-CANCER.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 82. ISSUE 6. P. 555-562 | 20 | 43% | 9 |
| 4 | LU, J , FRASER-REID, B , (2005) THE ANTITUBERCULOSIS, ANTITUMOR, MULTIBRANCHED DODECAFURANOARABINAN OF MYCOBACTERIUM SPECIES HAS BEEN ASSEMBLED FROM A SINGLE N-PENTENYLFURANOSIDE SOURCE.CHEMICAL COMMUNICATIONS. VOL. . ISSUE 7. P. 862 -864 | 11 | 44% | 20 |
| 5 | JENSEN, SE , HUBRECHTS, P , KLEIN, BM , HASLOV, KR , (2008) DEVELOPMENT AND VALIDATION OF AN ATP METHOD FOR RAPID ESTIMATION OF VIABLE UNITS IN LYOPHILISED BCG DANISH 1331 VACCINE.BIOLOGICALS. VOL. 36. ISSUE 5. P. 308 -314 | 7 | 64% | 9 |
| 6 | NODA, K , OHASHI, Y , SUGIMORI, H , OZAKI, M , NIIBE, H , OGITA, S , KOHNO, I , HASEGAWA, K , KIKUCHI, Y , TAKEGAWA, Y , ET AL (2006) PHASE III DOUBLE-BLIND RANDOMIZED TRIAL OF RADIATION THERAPY FOR STAGE IIIB CERVICAL CANCER IN COMBINATION WITH LOW-OR HIGH-DOSE Z-100: TREATMENT WITH IMMUNOMODULATOR, MORE IS NOT BETTER.GYNECOLOGIC ONCOLOGY. VOL. 101. ISSUE 3. P. 455-463 | 10 | 45% | 11 |
| 7 | YAMASHOJI, S , ASAKAWA, A , KAWASAKI, S , KAWAMOTO, S , (2004) CHEMILUMINESCENT ASSAY FOR DETECTION OF VIABLE MICROORGANISMS.ANALYTICAL BIOCHEMISTRY. VOL. 333. ISSUE 2. P. 303-308 | 8 | 57% | 13 |
| 8 | GROVES, MJ , (1997) BCG: THE PAST, PRESENT AND FUTURE OF A TUBERCULOSIS VACCINE.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 49. ISSUE . P. 7-15 | 13 | 43% | 5 |
| 9 | SASAKI, H , KOBAYASHI, M , EMORI, Y , OHYA, O , HAYASHI, Y , NOMOTO, K , (1997) Z-100, A POLYSACCHARIDE-RICH PREPARATION EXTRACTED FROM THE HUMAN TYPE MYCOBACTERIUM TUBERCULOSIS, IMPROVES THE RESISTANCE OF METH-A TUMOR-BEARING MICE TO ENDOGENOUS SEPTIC INFECTION.BIOTHERAPY. VOL. 10. ISSUE 2. P. 139-143 | 8 | 62% | 5 |
| 10 | HAYASHI, Y , SASAKI, H , EMORI, Y , NOMOTO, K , (1993) THE EFFECT OF COMBINATION THERAPY OF RADIATION AND Z-100, AN ARABINOMANNAN ON TUMOR-GROWTH IN MICE.BIOTHERAPY. VOL. 7. ISSUE 1. P. 63-69 | 7 | 78% | 6 |
Classes with closest relation at Level 1 |